Position in ANIP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$44,403,770
+$6,784,214 QoQ
Shares Held
536,407
+9.6% QoQ
Ownership
2.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 305 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. ANIP ranks #16 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in ANIP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,403,770 | 536,407 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $37,619,556 | 489,201 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $37,675,851 | 477,272 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $41,954,081 | 458,014 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $27,897,376 | 427,546 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $28,763,460 | 429,626 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $23,715,064 | 428,999 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $25,368,922 | 425,225 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $25,975,771 | 407,911 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $23,460,233 | 339,364 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,179,051 | 329,689 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $18,655,897 | 321,321 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,195,024 | 263,701 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,735,570 | 245,105 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,629,010 | 239,349 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,353,374 | 228,792 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,878,841 | 231,845 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,507,198 | 195,916 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,375,114 | 203,453 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,350,874 | 163,037 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,078,441 | 173,422 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,782,905 | 160,014 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,077,622 | 140,414 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,090,450 | 145,000 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,531,868 | 140,132 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,551,884 | 136,276 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||